期刊文献+

大鼠肝癌变进程中ACP、ALP活性变化及意义 被引量:2

下载PDF
导出
摘要 目的观察SD大鼠肝癌变进程中酸性磷酸酶(ACP)、碱性磷酸酶(ALP)活性变化,探讨其意义。方法用1%DENA水溶液灌胃诱发肝癌,每周1次,分别于第14、28、56、77、105、112天各处死10只大鼠,取其肝脏作病理切片,并用同工酶电泳法检测ACP、ALP活性。结果第14天开始,ACP、ALP活性随诱癌时间延长和肿瘤的发生发展逐渐升高,第77天最高,其后略有下降,但仍维持在高水平。结论在SD大鼠肝癌变进程中,ACP、ALP活性逐渐升高。
出处 《山东医药》 CAS 北大核心 2009年第34期27-28,共2页 Shandong Medical Journal
  • 相关文献

参考文献11

二级参考文献26

  • 1杭振镳 蔡文琴.电子显微技术在临床医学的应用[M].重庆:重庆出版社,1988.129-135.
  • 2Leuschner M,Dietrich C F, You T,et al. Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment[J]. Gut, 2000,46:121-126.
  • 3Dickson ER,Grambsch PM, Fleming TR, et al. Prognosis in primary biliary cirrhosis: model for decision making[J].Hepatology, 1989,10:1-7.
  • 4Poupon RE, Ouguerram K, Chretien Y, et al. Cholesterollowing effect of ursodeoxycholic acid in patients with primary biliary cirrhosis[J]. Hepatology, 1993,17:577-582.
  • 5Klein R, Huizenga SR, Gips CH, et al. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titers of antimitochondrial antibody-subtypes after transplantation[J]. J Hepatol, 1994,20:181-189.
  • 6Metcalf JV, Mitchison HC, Parmer JM, et al. Natural history of early primary biliary cirrhosis[J]. Lancet, 1996,348:1399-1402.
  • 7Heathcote EJ. Management of primary biliary cirrhosis[J].Hepatology, 2000,31:1005-1013.
  • 8Lacerda MA, Ludwig J, Dickson ER, et al. Antimitochondrial antibody-negative primary biliary cirrhosis[J]. Am J Gastroenterol, 1995,90: 247-249.
  • 9Bandin O, Courvalin J, Poupon R, et al. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis[J]. Hepatology, 1996,23:1020-1024.
  • 10Itoh S, Ichida T, Yoshida T, et al. Autoantibodies against a 210kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis [J]. J Gastroenterol Hepatol, 1998,13: 257-265.

共引文献24

同被引文献34

  • 1蒋兴亮,唐中.双试剂直接分光光度法测定血清总铁结合力[J].国际检验医学杂志,2006,27(1):7-9. 被引量:2
  • 2李亚里,杨怡卓.人乳头瘤病毒亚型检测在宫颈病变分流管理中的意义[J].中国实用妇科与产科杂志,2007,23(7):501-503. 被引量:55
  • 3卫生部临床检验中心,张传宝,张克坚.方法对比及偏差评估的方法一介绍NCCLS文件EP9-A[C].临床实验室质量管理文件汇编,2002:169-185.
  • 4National committee for clinical laboratory standards.Method comparison and bias estimation using patient samples;approved guideline,EP9-A[M].Pennsylvania.NCCLS,1986:1-14.
  • 5Tietz NW,Shuey DF.Reference intervals for alkaline phosphatase activity determined by the IFCC and AACC reference methods[J].Clin Chem,1986,32(8):1593-1594.
  • 6Lim CW,Vallis LM,Chisnall WN.Alkaline phosphatase activities in fresh serum and lyophilized controls by the AACC reference method or IFCC method compared with that of Bowers and McComb[J].Clin Chem,1986,32(12):2205.
  • 7Beaudenon S, Huibregtse JM. HPV E6, E6AP and cervical cancer. BMC Biochem,2008, 21 (9sl) : $4.
  • 8Bian ML. Brief introduction of the practical guideline about preventing and curing cervical cancer by WHO (2006). Chin J Pract Gynecol Obstet, 2007,23 (7) :557 - 560.
  • 9Kitchener HC, Castle PE, Cox JT. Achievements and limita- tions of cervical cytology screening. Vaccine, 2006,24 ( 3 ) : 63 - 70.
  • 10Arbyn M, Abarca M. Systematic review and meta - analysis. Brussels : Scientific Institute of Public Health ,2006 : 1 - 201.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部